BioCentury | Apr 13, 2007
Financial News

Novelos raises $15 million

...also received five-year warrants to purchase 7.5 million shares at $1.25 per share. Investors included Xmark Opportunity Funds...
BioCentury | Mar 6, 2006
Company News

Arius board of directors update

...Gordon, a general partner at OrbiMed Advisors LLC; and Mitchell Kaye, chief investment officer at Xmark Opportunity Funds...
Items per page:
1 - 2 of 2
BioCentury | Apr 13, 2007
Financial News

Novelos raises $15 million

...also received five-year warrants to purchase 7.5 million shares at $1.25 per share. Investors included Xmark Opportunity Funds...
BioCentury | Mar 6, 2006
Company News

Arius board of directors update

...Gordon, a general partner at OrbiMed Advisors LLC; and Mitchell Kaye, chief investment officer at Xmark Opportunity Funds...
Items per page:
1 - 2 of 2